Zimmer Biomet Holdings Inc.

ZBH-N

NYSE:ZBH

145.26
1.30 (0.89%)
Zimmer Biomet is a publicly traded medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
More at Wikipedia

Analysis and Opinions about ZBH-N

Signal
Opinion
Expert
COMMENT
COMMENT
February 14, 2020

Investing in healthcare is hard. He holds BDX which he sees it as the shopping mall of healthcare products. He used to own ZBH but they suffered from recalls. He would probably stick to one of the three since he believes they are the best run companies in healthcare.

Show full opinionHide full opinion

Investing in healthcare is hard. He holds BDX which he sees it as the shopping mall of healthcare products. He used to own ZBH but they suffered from recalls. He would probably stick to one of the three since he believes they are the best run companies in healthcare.

DON'T BUY
DON'T BUY
March 21, 2018

Their business is orthopedics (hips and knees). Have had shipping problems to customers and a received an FDA 483 notice (inspection) to one of their facilities. This will take a while to turn around. Better to buy Stryker.

Show full opinionHide full opinion

Their business is orthopedics (hips and knees). Have had shipping problems to customers and a received an FDA 483 notice (inspection) to one of their facilities. This will take a while to turn around. Better to buy Stryker.

PAST TOP PICK
PAST TOP PICK
February 1, 2018

(A Top Pick Feb 2/17, Up 8.90%) A great US company. He likes the medical device companies. These devices are going to be demanded more and more as we all get older.

Show full opinionHide full opinion

(A Top Pick Feb 2/17, Up 8.90%) A great US company. He likes the medical device companies. These devices are going to be demanded more and more as we all get older.

PAST TOP PICK
PAST TOP PICK
November 14, 2017

(A Top Pick Oct 13/16. Down 11%.) This is medical parts, knees, hips, spinal fusion products, etc. Had felt the stock would benefit from aging baby boomers. However, they had some inventory problems, and didn’t experience the kind of growth he expected. It’s still a great place to be.p

Show full opinionHide full opinion

(A Top Pick Oct 13/16. Down 11%.) This is medical parts, knees, hips, spinal fusion products, etc. Had felt the stock would benefit from aging baby boomers. However, they had some inventory problems, and didn’t experience the kind of growth he expected. It’s still a great place to be.p

TOP PICK
TOP PICK
February 2, 2017

We need hips and knees and are looking to the US for them. PE is 14-15 times earnings, to shield your capital from a slow decline in the Canadian dollar. The US dollar has been a one way trade. (Analysts’ target: $134.00).

Show full opinionHide full opinion

We need hips and knees and are looking to the US for them. PE is 14-15 times earnings, to shield your capital from a slow decline in the Canadian dollar. The US dollar has been a one way trade. (Analysts’ target: $134.00).

COMMENT
COMMENT
November 30, 2016

Thinks it is time to look at certain parts of healthcare. The situation is a little muddied, because we are faced with changes to the Affordable Care Act, and are not sure what form they are going to take and who it is going to affect. This company is a maker of joints, artificial hips, etc. There is some risk of competition and commoditization of these devices. He would probably look for another area in the healthcare arena. Some of the larger insurers are very interesting.

Show full opinionHide full opinion

Thinks it is time to look at certain parts of healthcare. The situation is a little muddied, because we are faced with changes to the Affordable Care Act, and are not sure what form they are going to take and who it is going to affect. This company is a maker of joints, artificial hips, etc. There is some risk of competition and commoditization of these devices. He would probably look for another area in the healthcare arena. Some of the larger insurers are very interesting.

Gordon Reid

Unlock Ratings

Price
$101.860
Owned
Unknown
HOLD
HOLD
October 31, 2016

They reported earnings that met expectations but guidance was tepid. It spooked the market with a suggestion of slower growth. Anything hinting at slower growth in the healthcare space has this effect. Short term investors should stay out of healthcare. 3-5 year horizon investors will find this a great company to hold.

Show full opinionHide full opinion

They reported earnings that met expectations but guidance was tepid. It spooked the market with a suggestion of slower growth. Anything hinting at slower growth in the healthcare space has this effect. Short term investors should stay out of healthcare. 3-5 year horizon investors will find this a great company to hold.

John Kim

Unlock Ratings

Price
$103.760
Owned
Unknown
TOP PICK
TOP PICK
October 13, 2016

The largest global supplier of artificial knees and hips. They also do disc back stabilization products as well as titanium teeth. Very well-run company, and trading at a very reasonable valuation. Did a big acquisition of Biomet and they expect $350 million of synergies. Dividend yield of 0.76%.

Show full opinionHide full opinion

The largest global supplier of artificial knees and hips. They also do disc back stabilization products as well as titanium teeth. Very well-run company, and trading at a very reasonable valuation. Did a big acquisition of Biomet and they expect $350 million of synergies. Dividend yield of 0.76%.

PAST TOP PICK
PAST TOP PICK
August 8, 2016

(Top Pick Aug 6/15, Up 30.22%) A spare parts company for humans. He knows so many people who are getting parts replaced or getting implants. The population is aging. Demographics change very, very slowly.

Show full opinionHide full opinion

(Top Pick Aug 6/15, Up 30.22%) A spare parts company for humans. He knows so many people who are getting parts replaced or getting implants. The population is aging. Demographics change very, very slowly.

BUY
BUY
October 14, 2015

It has not done well recently. Hip and Knee replacement. People are getting older and there will be more replacements in the future. He is happy to buy it here for the long term.

Show full opinionHide full opinion

It has not done well recently. Hip and Knee replacement. People are getting older and there will be more replacements in the future. He is happy to buy it here for the long term.

TOP PICK
TOP PICK
August 6, 2015

They are primarily in the business of artificial knees and hips. Lots of baby boomers starting to wear out their joints and needing new ones. It is a growth industry. It has 75% gross margin. It has the best value in this sector.

Show full opinionHide full opinion

They are primarily in the business of artificial knees and hips. Lots of baby boomers starting to wear out their joints and needing new ones. It is a growth industry. It has 75% gross margin. It has the best value in this sector.

TOP PICK
TOP PICK
May 7, 2015

Hips, knees and extremities. Demand will grow 4-6% over the long term. They have not yet expanded outside of North America. People are getting older and the number of 60 year olds is getting wider and they wear out their hips and knees. They don’t have a lot of pricing power, but have certainty in the need for the products. It sold off recently from currency exposure. The value is quite reasonable here. They have a great track record of increasing dividends and buying back stock.

Show full opinionHide full opinion

Hips, knees and extremities. Demand will grow 4-6% over the long term. They have not yet expanded outside of North America. People are getting older and the number of 60 year olds is getting wider and they wear out their hips and knees. They don’t have a lot of pricing power, but have certainty in the need for the products. It sold off recently from currency exposure. The value is quite reasonable here. They have a great track record of increasing dividends and buying back stock.

PAST TOP PICK
PAST TOP PICK
December 8, 2014

(A Top Pick Nov 20/13. Up 29.78%.) Announced an acquisition, so had a good pop to it, so she sold her stake into that.

Show full opinionHide full opinion

(A Top Pick Nov 20/13. Up 29.78%.) Announced an acquisition, so had a good pop to it, so she sold her stake into that.

BUY
BUY
June 23, 2014

She held it in her portfolios because of the valuation and demographics. She sold into that big spike on the announcement when they made an acquisition. It has drifted down and now has come back up. There seem to be a lot of synergies. They are in the same town. There is compelling value there now. If you have a longer time horizon it will probably do well for you. She owns another medical stock.

Show full opinionHide full opinion

She held it in her portfolios because of the valuation and demographics. She sold into that big spike on the announcement when they made an acquisition. It has drifted down and now has come back up. There seem to be a lot of synergies. They are in the same town. There is compelling value there now. If you have a longer time horizon it will probably do well for you. She owns another medical stock.

BUY
BUY
May 2, 2014

A top pick tonight is a competitor. Healthcare is economically sensitive and the body parts business is extremely economically sensitive. If you don’t have insurance, it costs a lot to fix them and a lot of this is elective. They are making an acquisition.

Show full opinionHide full opinion

A top pick tonight is a competitor. Healthcare is economically sensitive and the body parts business is extremely economically sensitive. If you don’t have insurance, it costs a lot to fix them and a lot of this is elective. They are making an acquisition.

Showing 1 to 15 of 21 entries

Zimmer Biomet Holdings Inc.(ZBH-N) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Zimmer Biomet Holdings Inc. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Zimmer Biomet Holdings Inc.(ZBH-N) Frequently Asked Questions

What is Zimmer Biomet Holdings Inc. stock symbol?

Zimmer Biomet Holdings Inc. is a American stock, trading under the symbol ZBH-N on the New York Stock Exchange (ZBH). It is usually referred to as NYSE:ZBH or ZBH-N

Is Zimmer Biomet Holdings Inc. a buy or a sell?

In the last year, there was no coverage of Zimmer Biomet Holdings Inc. published on Stockchase.

Is Zimmer Biomet Holdings Inc. a good investment or a top pick?

Zimmer Biomet Holdings Inc. was recommended as a Top Pick by Barry Schwartz on 2020-02-14. Read the latest stock experts ratings for Zimmer Biomet Holdings Inc..

Why is Zimmer Biomet Holdings Inc. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Zimmer Biomet Holdings Inc. worth watching?

In the last year, there was no coverage of Zimmer Biomet Holdings Inc. published on Stockchase.

What is Zimmer Biomet Holdings Inc. stock price?

On 2020-02-27, Zimmer Biomet Holdings Inc. (ZBH-N) stock closed at a price of $145.26.